| 2024 |
Rogers, A., De Jong, L., Waters, W., Rawlings, L. H., Simons, K., Gao, S., . . . Kassahn, K. S. (2024). Extending the new era of genomic testing into pregnancy management: A proposed model for Australian prenatal services. Australian and New Zealand Journal of Obstetrics and Gynaecology, 8 pages.
DOI Scopus1 Europe PMC1 |
| 2023 |
Byrne, A. B., Arts, P., Ha, T. T., Kassahn, K. S., Pais, L. S., O'Donnell-Luria, A., . . . Webber, D. L. (2023). Genomic autopsy to identify underlying causes of pregnancy loss and perinatal death. Nature Medicine, 29(1), 180-189.
DOI Scopus20 WoS5 Europe PMC12 |
| 2023 |
Homan, C. C., Drazer, M. W., Yu, K., Lawrence, D. M., Feng, J., Arriola-Martinez, L. A., . . . Brown, A. L. (2023). Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants. Blood Advances, 7(20), 6092-6107.
DOI Scopus15 Europe PMC10 |
| 2022 |
Drazer, M. W., Homan, C. C., Yu, K., Cavalcante de Andrade Silva, M., McNeely, K. E., Pozsgai, M. J., . . . Godley, L. A. (2022). Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations.. Blood Adv, 6(15), 4357-4359.
DOI Scopus16 WoS4 Europe PMC9 |
| 2022 |
Tudini, E., Andrews, J., Lawrence, D. M., King-Smith, S. L., Baker, N., Baxter, L., . . . Shariant Consortium. (2022). Shariant platform: Enabling evidence sharing across Australian clinical genetic-testing laboratories to support variant interpretation.. American journal of human genetics, 109(11), 1960-1973.
DOI Scopus13 WoS2 Europe PMC12 |
| 2021 |
Homan, C. C., King-Smith, S. L., Lawrence, D. M., Arts, P., Feng, J., Andrews, J., . . . Brown, A. L. (2021). The RUNX1 Database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy.. Haematologica, 106(11), 3004-3007.
DOI Scopus31 WoS20 Europe PMC15 |
| 2021 |
Homan, C. C., Venugopal, P., Arts, P., Shahrin, N. H., Feurstein, S., Rawlings, L., . . . Hahn, C. N. (2021). GATA2 deficiency syndrome: a decade of discovery. Human Mutation, 42(11), 1399-1421.
DOI Scopus34 WoS13 Europe PMC23 |
| 2021 |
Homan, C. C., Venugopal, P., Arts, P., Shahrin, N. H., Feurstein, S., Rawlings, L., . . . Hahn, C. N. (2021). Cover, Volume 42, Issue 11. Human Mutation, 42(11).
DOI |
| 2018 |
Pillman, K. A., Phillips, C. A., Roslan, S., Toubia, J., Dredge, B. K., Bert, A. G., . . . Gregory, P. A. (2018). miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking. EMBO Journal, 37(13), 20 pages.
DOI Scopus82 WoS64 Europe PMC58 |
| 2017 |
Lumb, R., Buckberry, S., Secker, G., Lawrence, D., & Schwarz, Q. (2017). Transcriptome profiling reveals expression signatures of cranial neural crest cells arising from different axial levels. BMC Developmental Biology, 17(1), 5-1-5-12.
DOI Scopus19 WoS18 Europe PMC15 |
| 2017 |
Venugopal, P., Moore, S., Lawrence, D., George, A., Hannan, R., Bray, S., . . . Scott, H. (2017). Self-reverting mutations partially correct the blood phenotype in a Diamond Blackfan Anemia patient. Haematologica, 102(12), e506-e509.
DOI Scopus24 WoS19 Europe PMC15 |
| 2017 |
Yu, F., Pillman, K., Neilsen, C., Toubia, J., Lawrence, D., Tsykin, A., . . . Bracken, C. (2017). Naturally existing isoforms of miR-222 have distinct functions. Nucleic Acids Research, 45(19), 11371-11385.
DOI Scopus58 WoS49 Europe PMC41 |
| 2017 |
Hewett, D., Vandyke, K., Lawrence, D., Friend, N., Noll, J., Geoghegan, J., . . . Zannettino, A. (2017). DNA barcoding reveals habitual clonal dominance of myeloma plasma cells in the bone marrow microenvironment. Neoplasia : An International Journal for Oncology Research, 19(12), 972-981.
DOI Scopus16 WoS12 Europe PMC12 |
| 2015 |
Thomson, D., Pillman, K., Anderson, M., Lawrence, D., Toubia, J., Goodall, G., & Bracken, C. (2015). Assessing the gene regulatory properties of Argonaute-bound small RNAs of diverse genomic origin. Nucleic Acids Research, 43(1), 470-481.
DOI Scopus33 WoS27 Europe PMC30 |
| 2015 |
Yu, F., Bracken, C., Pillman, K., Lawrence, D., Goodall, G., Callen, D., & Neilsen, P. (2015). p53 represses the oncogenic Sno-MiR-28 derived from a SnoRNA. PLoS One, 10(6), e0129190-1-e0129190-20.
DOI Scopus59 WoS49 Europe PMC43 |
| 2015 |
Kazenwadel, J., Betterman, K., Chong, C., Stokes, P., Lee, Y., Secker, G., . . . Harvey, N. (2015). GATA2 is required for lymphatic vessel valve development and maintenance. Journal of Clinical Investigation, 125(8), 2979-2994.
DOI Scopus175 WoS138 Europe PMC116 |
| 2015 |
Lim, S., Qu, Z., Kortschak, R., Lawrence, D., Geoghegan, J., Hempfling, A., . . . O'Bryan, M. (2015). HENMT1 and piRNA stability are required for adult male germ cell transposon repression and to define the spermatogenic program in the mouse. PLoS Genetics, 11(10), e1005620-1-e1005620-30.
DOI Scopus94 WoS76 Europe PMC73 |
| 2015 |
Lim, S. L., Qu, Z. P., Kortschak, R. D., Lawrence, D. M., Geoghegan, J., Hempfling, A. -L., . . . O'Bryan, M. K. (2015). Correction: HENMT1 and piRNA Stability Are Required for Adult Male Germ Cell Transposon Repression and to Define the Spermatogenic Program in the Mouse.. PLoS genetics, 11(12), e1005782.
DOI Europe PMC2 |
| 2014 |
Bracken, C. P., Li, X., Wright, J. A., Lawrence, D., Pillman, K. A., Salmanidis, M., . . . Goodall, G. (2014). Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasion. The EMBO Journal, 33(18), 1979-2134.
DOI Scopus121 WoS116 Europe PMC94 |
| 2014 |
Pishas, K., Neuhaus, S., Clayer, M., Schreiber, A., Lawrence, D., Perugini, M., . . . Neilsen, P. (2014). Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling. Cancer Research, 74(3), 921-931.
DOI Scopus22 WoS22 Europe PMC17 |
| 2014 |
Parker, W. T., Phillis, S. R., Yeung, D. T., Lawrence, D., Schreiber, A., Wang, P., . . . Branford, S. (2014). Detection of BCR-ABL1 Compound and Polyclonal Mutants in Chronic Myeloid Leukemia Patients Using a Novel Next Generation Sequencing Approach That Minimises PCR and Sequencing Errors. Blood, 124(21), 399.
DOI |
| 2013 |
Attema, J., Bert, A., Lim, Y., Kolesnikoff, N., Lawrence, D., Pillman, K., . . . Goodall, G. (2013). Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast cancer cells. PLoS One, 8(9), 1-15.
DOI Scopus20 WoS18 Europe PMC13 |
